Table 5.
Disease/age group | Children and adolescents (<18 years) | Adults (>18 years) |
---|---|---|
Priority vaccinations | ||
MMR | Administer to individuals ≥9 months of age. Two doses of MMRa should be administered at least 1 month apart but preferably longer according to national guidelines. Measles vaccine provided before 12 months of age does not induce protection in all and should be repeated after 12 months of age. | Administer one or two doses of MMR to all individuals, according to national guidelines.a |
Diphtheria, tetanus, pertussis, polio and Hib | Administer to individuals ≥2months, three doses of DTaP-IPV-Hib (Hib-component only for children <6 years unless other country-specific recommendations) containing vaccines at least 1 month apart, followed by a booster dose according to national guidelines. Pentavalent and hexavalent combination vaccines are authorized up to 6 years of age. | Administer to all adults, three doses of TdaPIPV-containing vaccinesb according to national guidelines. |
To be considered | ||
Hepatitis B | Administer to individuals ≥2 months, three doses according to national guidelines.c Administer to new-born infants of HBsAg-positive mothers within 24 hours of birth, according to national guidelines. | Administer to all adults, with or without previous screening, according to national guidelines. |
Meningococcal disease | National guidelines for meningococcal vaccines against serogroups A, B, C, W135 and Y should be followed, unless the epidemiological situation suggests otherwise. | |
Pneumococcal disease | Administer to individuals ≥2 months with one to three doses of conjugate vaccine at least 1 month apart, according to national guidelines. | Administer to individuals ≥65 years, according to national guidelines. |
Varicella | National guidelines should be followed unless the epidemiological situation suggests otherwise. If used, administer to individuals ≥11 months of age, two doses of varicella at least 1 month apart, but preferably longer. | National guidelines should be followed unless the epidemiological situation suggests otherwise. Consider vaccinating non-immune non-pregnant women of childbearing age. |
Influenza | National guidelines should be followed unless the epidemiological situation suggests otherwise. Consider vaccinating risk groups over 6 months of age ahead of and during influenza season. | National guidelines should be followed unless the epidemiological situation suggests otherwise. Consider vaccinating risk groups, including pregnant women, ahead of and during influenza season. |
Tuberculosis | Administer BCG according to national guidelines. Re-vaccination with BCG is not recommended. | BCG is generally not recommended for adults, unless specific reasons suggest otherwise. |
MMR means measles/mumps/rubella;
EU means European Union;
EEA means European Economic Area.
aMMR vaccine is contra-indicated in immunocompromised individuals and during pregnancy. Pregnancy should be avoided for one month after MMR vaccination.
bIf there is a vaccine shortage administer at least one dose of vaccine containing a cellular pertussis component.
cTesting for hepatitis B virus infection (HBsAg) could be done before the vaccine is administered.